Manufacturer record
Halewood Laboratories Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Halewood Laboratories Pvt. Ltd (Gujarat) were declared Not of Standard Quality between March 2019 and December 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BN9002, Etofylline & Theophylline Tablets IP (exp Mar 2022). CDTL Mumbai (CDSCO lab) found it not of standard quality: Disintegration. Listed in the December 2019 alert.
Records by type
2 records linked to Halewood Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Etofylline & Theophylline Tablets IP | Batch BN9002Mfg Apr 2019 · Exp Mar 2022 | DisintegrationDisintegration | CDTL MumbaiCDSCO lab | Dec 2019 |
| AZITHROMYCIN tablets I.P. 500mg. | Batch AS7001Mfg Sep 2017 · Exp Aug 2019 | DissolutionDissolution | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.